Department of Psychosocial Science, University of Bergen, Christiesgate 12, 5015, Bergen, Norway.
Optentia, the Vaal Triangle Campus of the North-West University, Vanderbijlpark, South Africa.
Psychopharmacology (Berl). 2021 Jul;238(7):1911-1922. doi: 10.1007/s00213-021-05818-7. Epub 2021 Mar 20.
Aggression and irritability are notable psychiatric side effects of anabolic-androgenic steroid (AAS) use. However, no previous study has systematically reviewed and quantitatively synthesized effects reported by experimental studies on this topic.
We conducted a systematic review and meta-analysis of randomized controlled trials (RCTs) investigating the effect of AAS administration on self-reported and observer-reported aggression.
Twelve RCTs comprising a total of 562 healthy males were identified through systematic searches of MEDLINE, PsycInfo, ISI Web of Science, ProQuest, Google Scholar, and the Cochrane Library.
After excluding one outlier, AAS administration was associated with an increase in self-reported aggression under a random-effects model, albeit small (Hedges' g = 0.171, 95% CI: 0.029-0.312, k = 11, p = .018), and when restricting the analysis to the effect of acute AAS administration on self-reported aggression under a fixed-effect model (g = 0.291, 95% CI: 0.014-0.524, p = .014). However, the above effects were neither replicated in the analysis of observer-reported aggression nor after restricting the analysis to the effects of the administration of higher (over 500 mg) and long-term (3 days to 14 weeks) doses.
The present meta-analysis provides evidence of an increase, although small, in self-reported aggression in healthy males following AAS administration in RCTs. Ecologically rational RCTs are warranted to better explore the effect of AAS administration on aggression in humans.
攻击性和易怒是合成代谢雄激素类固醇(AAS)使用的显著精神副作用。然而,以前没有研究系统地回顾和定量综合这一主题的实验研究报告的影响。
我们对调查 AAS 给药对自我报告和观察者报告的攻击性影响的随机对照试验(RCT)进行了系统评价和荟萃分析。
通过对 MEDLINE、PsycInfo、ISI Web of Science、ProQuest、Google Scholar 和 Cochrane 图书馆进行系统搜索,确定了 12 项共包含 562 名健康男性的 RCT。
在排除一个异常值后,AAS 给药与自我报告的攻击性增加相关,尽管幅度较小(随机效应模型下的 Hedges' g = 0.171,95%置信区间:0.029-0.312,k = 11,p =.018),并且当将分析限制为急性 AAS 给药对自我报告的攻击性影响的固定效应模型时(g = 0.291,95%置信区间:0.014-0.524,p =.014)。然而,在观察者报告的攻击性分析中,或在将分析限制为更高(超过 500 毫克)和长期(3 天至 14 周)剂量的给药效果时,均未复制上述效果。
本荟萃分析提供了证据,表明在 RCT 中,AAS 给药后健康男性的自我报告攻击性增加,尽管幅度较小。有必要进行生态合理的 RCT,以更好地探索 AAS 给药对人类攻击性的影响。